🇺🇸 Praxilene in United States

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Praxilene (naftidrofuryl oxalate) regulatory status in United States.

Marketing authorisation

FDA

Status: approved

Other Metabolic approved in United States

Frequently asked questions

Is Praxilene approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Praxilene in United States?

Merck Serono (originally Lipha) is the originator. The local marketing authorisation holder may differ — check the official source linked above.